This selectivity in blocking effector CD4 T cell recruitment while preserving the presence of immunomodulatory Tregs may have played a crucial role in the effectiveness of α4β7 and MAdCAM-1 mAbs in suppressing hepatic fibrosis. Here, CD4 is linked to Hepatic fibrosis.